Placental Abruption

2

Review clinical trials related to Placental Abruption. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy

A randomized clinical trial to assess the efficiency of acetylsalicylic acid (aspirin) 150 mg/day started before 20 weeks of gestation in the prevention on maternal and fœtal complications in pregnant women with chronic hypertension.

Participants needed: 500
Trial details
Phase: Phase 3Age: 18+Biological sex: FemaleType: InterventionalSponsor: Centre Hospitalier Intercommunal CreteilUpdated: Jun 12, 2026Locations: 20
Eligibility criteria

Pregnant patient between 10 and 19 weeks of gestation + 6 days [+4]

---Medical history requiring anticoagulation (antiphospholipid syndrome, deep ve... [+19]

Status: Recruiting

PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)

The aim of this prospective observational cohort study is to investigate the pathophysiological mechanisms behind and risk of pre-eclampsia in women pregnant after fertility treatment with oocyte donation. The participants are included in of of two cohorts. One includes women pregnant after oocyte donation whereas the other includes women pregnant after IVF treatment with autologous oocytes. Participants will be followed throughout pregnancy with blood samples, blood pressure, clinical controls and ultrasound examinations. Clinical outcomes will be registered post-partum.

Participants needed: 462
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Copenhagen University Hospital, HvidovreUpdated: Apr 13, 2026Locations: 6
Eligibility criteria

Age > 18 years [+4]

Age < 18 years [+17]